Neuroradiological differentiation of white matter lesions in patients with multiple sclerosis and Fabry disease.


Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
05 02 2022
Historique:
received: 20 12 2021
accepted: 21 01 2022
entrez: 6 2 2022
pubmed: 7 2 2022
medline: 12 3 2022
Statut: epublish

Résumé

White matter lesions (WML) in multiple sclerosis (MS) differ from vascular WML caused by Fabry disease (FD). However, in atypical cases the discrimination can be difficult and may vary between individual raters. The aim of this study was to evaluate interrater reliability of WML differentiation between MS and FD patients. Brain MRI scans of 21 patients with genetically confirmed FD were compared to 21 matched patients with MS. Pseudonymized axial FLAIR sequences were assessed by 6 blinded raters and attributed to either the MS or the FD group to investigate interrater reliability. Additionally, localization of WML was compared between the two groups. The median age of patients was 46 years (IQR 35-58). Interrater reliability was moderate with a Fleiss' Kappa of 0.45 (95%CI 0.3-0.59). Overall, 85% of all ratings in the MS group and 75% in the FD group were correct. However, only 38% of patients with MS and 33% of patients with FD were correctly identified by all 6 raters. WML involving the corpus callosum (p < 0.001) as well as juxtacortical (p < 0.001) and infratentorial lesions (p = 0.03) were more frequently observed in MS patients. Interrater reliability regarding visual differentiation of WML in MS from vascular WML in FD on standard axial FLAIR images alone is only moderate, despite the distinctive features of lesions in each group.

Identifiants

pubmed: 35123534
doi: 10.1186/s13023-022-02187-y
pii: 10.1186/s13023-022-02187-y
pmc: PMC8817613
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

37

Informations de copyright

© 2022. The Author(s).

Références

Cerebrovasc Dis. 2002;13 Suppl 2:21-30
pubmed: 11901239
Radiology. 1999 Jan;210(1):149-53
pubmed: 9885600
Brain Pathol. 2017 Nov;27(6):707-722
pubmed: 27864848
Mult Scler. 2014 Jan;20(1):57-63
pubmed: 23736535
Acta Neuropathol. 2011 Aug;122(2):171-85
pubmed: 21706175
Radiology. 1986 Aug;160(2):363-7
pubmed: 3726114
Mult Scler. 2021 Feb;27(2):250-258
pubmed: 32162581
BMJ Case Rep. 2017 Jun 2;2017:
pubmed: 28576916
Mult Scler. 2013 Jul;19(8):1101-5
pubmed: 23380650
Mult Scler. 2016 Sep;22(10):1289-96
pubmed: 26658816
BMC Med Res Methodol. 2016 Aug 05;16:93
pubmed: 27495131
Neuroradiology. 2017 Jun;59(6):563-570
pubmed: 28386689
Mult Scler. 2020 Apr;26(4):421-432
pubmed: 31536435
Lancet Neurol. 2006 Sep;5(9):791-5
pubmed: 16914407
Stroke. 2015 Jun;46(6):1548-53
pubmed: 25899239
Continuum (Minneap Minn). 2019 Jun;25(3):611-635
pubmed: 31162308
Clin Radiol. 2016 Sep;71(9):815-27
pubmed: 27349475
Radiology. 1991 Jul;180(1):215-21
pubmed: 2052698
Mult Scler. 2016 Oct;22(12):1578-1586
pubmed: 26769065
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
AJNR Am J Neuroradiol. 2003 May;24(5):916-21
pubmed: 12748094
Mult Scler Relat Disord. 2019 May;30:45-47
pubmed: 30738278
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Nat Rev Neurol. 2018 Mar 20;14(4):213
pubmed: 29582852
Nat Rev Neurol. 2016 Dec;12(12):714-722
pubmed: 27834394
AJNR Am J Neuroradiol. 2017 Dec;38(12):2264-2269
pubmed: 29051208
Neurology. 2016 Sep 27;87(13):1393-9
pubmed: 27581217
Lancet Neurol. 2016 Mar;15(3):292-303
pubmed: 26822746
Mult Scler Relat Disord. 2015 Mar;4(2):170-5
pubmed: 25787193
Radiology. 2012 Dec;265(3):926-32
pubmed: 23074257
J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):9-14
pubmed: 11118240
Brain Behav. 2018 Nov;8(11):e01121
pubmed: 30277321
Neurol Neuroimmunol Neuroinflamm. 2018 Sep 26;5(6):e496
pubmed: 30345329
PLoS One. 2013 Aug 28;8(8):e71894
pubmed: 24015197
J Neuroimaging. 2017 Nov;27(6):613-619
pubmed: 28488804
Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S80-4
pubmed: 26486298
Brain. 1997 Nov;120 ( Pt 11):2059-69
pubmed: 9397021
Lancet. 2008 Oct 18;372(9647):1427-35
pubmed: 18940466
JAMA Neurol. 2019 Dec 1;76(12):1446-1456
pubmed: 31424490
Brain. 2019 Jul 1;142(7):1858-1875
pubmed: 31209474

Auteurs

Jakob Rath (J)

Department of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Olivia Foesleitner (O)

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Lukas Haider (L)

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
NMR Research Unit, Queens Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Science, University College London, Russel Square, London, UK.

Hubert Bickel (H)

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Fritz Leutmezer (F)

Department of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Stephan Polanec (S)

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Michael A Arnoldner (MA)

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Gere Sunder-Plassmann (G)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Daniela Prayer (D)

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Thomas Berger (T)

Department of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Paulus Rommer (P)

Department of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. paulus.rommer@meduniwien.ac.at.

Gregor Kasprian (G)

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH